Diabetic background retinopathy is associated with impaired coronary vasoreactivity in people with Type 1 diabetes

Diabetologia

Volumn 47, Issue 4, 2004, Pages 725-731

  Sundell, J ^a,b   Janatuinen, T ^a   Ronnemaa T ^b   Raitakari, O T ^a,b   Toikka, J ^b   Nuutila, P ^a,b   Knuuti, J ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Dipyridamole; Myocardial blood flow; Positron emission tomography; Retinopathy; Type 1 diabetes

Indexed keywords

CHOLESTEROL; DIPYRIDAMOLE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; WATER O 15;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; CORONARY VASCULAR RESISTANCE; DIABETIC RETINOPATHY; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HEART MUSCLE BLOOD FLOW; HEART RATE; HEMODYNAMIC PARAMETERS; HUMAN; HYPEREMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLIC PARAMETERS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REST; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CORONARY CIRCULATION; CORONARY VESSELS; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; DIPYRIDAMOLE; FEMALE; GLUCOSE CLAMP TECHNIQUE; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; OXYGEN RADIOISOTOPES; POSITRON-EMISSION TOMOGRAPHY; RISK FACTORS; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 2442709198     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1340-8     Document Type: Article

References (34)

1. Klein R, Klein BE, Moss SE (1992) Epidemiology of proliferative diabetic retinopathy. Diabetes Care 15:1875-1891
2. Hiller R, Sperduto RD, Podgor MJ, Ferris FL 3rd, Wilson PW (1988) Diabetic retinopathy and cardiovascular disease in type II diabetics. The Framingham Heart Study and the Framingham Eye Study. Am J Epidemiol 128:402-409
3. Yoon JK, Lee KH, Park JM et al. (2001) Usefulness of diabetic retinopathy as a marker of risk for thallium myocardial perfusion defects in non-insulin-dependent diabetes mellitus. Am J Cardiol 87:456-459, A6
4. Pitkanen OP, Raitakari OT, Ronnemaa T et al. (1997) Influence of cardiovascular risk status on coronary flow reserve in healthy young men. Am J Cardiol 79:1690-1692
5. Leung WH, Lau CP, Wong CK (1993) Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet 341:1496-1500
6. Janatuinen T, Laaksonen R, Vesalainen R et al. (2001) Effect of lipid-lowering therapy with pravastatin on myocardial blood flow in young mildly hypercholesterolemic adults. J Cardiovasc Pharmacol 38:561-568
7. Anonymous (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98 [Suppl 5]:786-806
8. Pitkanen OP, Nuutila P, Raitakari OT et al. (1998) Coronary flow reserve is reduced in young men with IDDM. Diabetes 47:248-254
9. Crouzel C, Clark J, Brihaye C, La°ngström B, Lemaire C, Meyer G, Nebeling B, Stone-Elander S (1993) Radiochemistry automation for PET. In: Stöckling G, Pike V (eds) Radiopharmaceuticals for positron emission tomography. Kluwer, Dordrecht, pp 45-90
10. 2O production system for heart and brain studies. J Labelled Compounds Radiopharm 44:S1066-S1068
11. Alenius S, Ruotsalainen U (1997) Bayesian image reconstruction for emission tomography based on median root prior. Eur J Nucl Med 24:258-265
12. Laine H, Raitakari OT, Niinikoski H et al. (1998) Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol 32:147-153
13. Iida H, Takahashi A, Tamura Y, Ono Y, Lammertsma AA (1995) Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation. J Nucl Med 36:78-85
14. Iida H, Rhodes CG, de Silva R et al. (1992) Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med 33:1669-1677
15. Taylor DJ, Fisher J, Jacob J, Tooke JE (1999) The use of digital cameras in a mobile retinal screening environment. Diabet Med 16:680-686
16. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
17. Kadish A, Little R, Sternberg J (1968) A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14:116-131
18. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
19. Scheid DC, McCarthy LH, Lawler FH, Hamm RM, Reilly KE (2001) Screening for microalbuminuria to prevent nephropathy in patients with diabetes: a systematic review of the evidence. J Fam Pract 50:661-668
20. Mayhan WG (1992) Endothelium-dependent responses of cerebral arterioles to adenosine 5′-diphosphate. J Vasc Res 29:353-358
21. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD (1990) Effects of adenosine on human coronary arterial circulation. Circulation 82:1595-1606
22. Buus NH, Bottcher M, Hermansen F et al. (2001) Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia. Circulation 104:2305-2310
23. Dayanikli F, Grambow D, Muzik O et al. (1994) Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation 90:808-817
24. Opie LH (1998) The heart, 3rd edn. Lippincott-Raven, Philadelphia New York
25. Halcox JP, Schenke WH, Zalos G et al. (2002) Prognostic value of coronary vascular endothelial dysfunction. Circulation 106:653-658
26. Schachinger V, Britten MB, Zeiher AM (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899-1906
27. Cecchi F, Olivotto I, Gistri R et al. (2003) Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 349:1027-1035
28. Stevens MJ, Dayanikli F, Raffel DM et al. (1998) Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. J Am Coll Cardiol 31:1575-1584
29. Nitenberg A, Valensi P, Sachs R et al. (1993) Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 42:1017-1025
30. Di Carli MF, Bianco-Batlles D, Landa ME et al. (1999) Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 100:813-819
31. Sundell J, Laine H, Nuutila P et al. (2002) The effects of insulin and short-term hyperglycemia on myocardial blood flow in young men with uncomplicated Type I diabetes. Diabetologia 45:775-782
32. Di Carli MF, Janisse J, Grunberger G, Ager J (2003) Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 41:1387-1393
33. Araujo LI, Lammertsma AA, Rhodes CG et al. (1991) Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation 83:875-885
34. 15O]water techniques. Circulation 93:2000-2006